Treatment of Isolated Extramedullary Relapse From Acute Lymphoblastic Leukemia (ALL) (Initial CR1greater than or equal to 18 Months).
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Cyclophosphamide; Cytarabine; Daunorubicin; Dexamethasone; Etoposide; Filgrastim; Folinic acid; Hydrocortisone; Mercaptopurine; Methotrexate; Pegaspargase; Vincristine
- Indications Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions; Therapeutic Use
- 21 Mar 2017 Biomarkers information updated
- 18 Jul 2012 Planned end date changed from 1 Nov 2008 to 1 Sep 2013 as reported by ClinicalTrials.gov.
- 18 Jul 2012 Status changed from suspended to active, no longer recruiting as reported by ClinicalTrials.gov.